戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e as the difference observed after a week of hospitalisation.
2 ther as a result of illness and particularly hospitalisation.
3 at high risk of venous thromboembolism after hospitalisation.
4 ounting for up to 30% of adult heart failure hospitalisations.
5  order, were found for psychiatric inpatient hospitalisation (adjusted relative risk [aRR] = 2.0; 95%
6 ses in 2013, -78%, 95% CI -72 to -83) and in hospitalisation admissions (440 admissions in 2012 vs 14
7 is 13 billion euros, mainly accounted for by hospitalisation after fracture.
8 photericin B administration requires patient hospitalisation and careful laboratory monitoring to ide
9 P) levels have been shown to predict risk of hospitalisation and death from COPD.
10 lose temporal association with heart failure hospitalisation and heart failure mortality.
11  acute decompensated heart failure including hospitalisation and heart failure mortality.
12                                              Hospitalisation and mortality events were documented for
13 reducing the delay between symptom onset and hospitalisation and rapid national and international res
14 uce the number and associated costs of child hospitalisations and clinical visits for acute diarrhoea
15       Three had severe disease with multiple hospitalisations and complications but responded promptl
16 food borne pathogen responsible for numerous hospitalisations and deaths all over the world.
17 .9 mug/m(3) would prevent 7978 heart failure hospitalisations and save a third of a billion US dollar
18 s not associated with a reduction in overall hospitalisations and was associated with an increase in
19 utcomes were: total, elective, and emergency hospitalisations, and total and GP-referred specialist v
20 es complications from abortion procedures or hospitalisation are rare.
21 dpoint was the rate of heart-failure-related hospitalisations at 6 months.
22 tion could lead to a substantial increase in hospitalisation because of dengue.
23 f outpatient specialist visits and inpatient hospitalisations before and after the implementation of
24 ent, including all cardiovascular deaths and hospitalisations, between 1989 and 1995.
25 s 29%, p=0.017), reduced duration of initial hospitalisation, but higher risk of chronic myelogenous
26 er country experienced a change in trends in hospitalisations: change in slope for total, elective, a
27 had a 39% reduction in heart-failure-related hospitalisation compared with the control group (153 vs
28              Safe funeral practices and fast hospitalisation contributed to the containment of this E
29 riven revascularisation and ischaemia-driven hospitalisation did not differ significantly between gro
30  nor was there a difference in the number of hospitalisations due to relapsing IBD during follow-up.
31 roid dosing protocol to periods of prolonged hospitalisation during the first 3 postoperative months
32 ation between depression and non-psychiatric hospitalisation episodes has never been researched in gr
33 t use and non-elective CEA (performed during hospitalisation for a symptomatic ipsilateral stroke, tr
34 h people with mental health problems) during hospitalisation for acute illness were analysed using a
35                                              Hospitalisation for adversity-related injury (violent, d
36  between intelligence and subsequent risk of hospitalisation for bipolar disorder in a prospective co
37 ite of time to death from any cause or first hospitalisation for cardiovascular reasons.
38 pation fails, the patient may need emergency hospitalisation for disimpaction.
39 tly lower in France, the UK and Germany, and hospitalisation for headache was significantly more freq
40 t ventricular (LV) systolic dysfunction, and hospitalisation for heart failure or intravenous drug th
41 widen understanding for the global burden of hospitalisation for hypoglycaemia.
42 bral malaria began to change 10 years before hospitalisation for malaria started to fall.
43 showing a significant and large reduction in hospitalisation for patients with NYHA class III heart f
44 er, nonliver, and all-cause mortality; first hospitalisation for severe liver morbidity (SLM); cardio
45 scular endpoint (which additionally included hospitalisation for unstable angina requiring unplanned
46 t non-fatal myocardial infarction or stroke, hospitalisation for unstable angina, arterial revascular
47 s-old young woman with a history of multiple hospitalisations for foci of vascular anomalies appearin
48 e show a significant increase (1.2%-267%) in hospitalisations for respiratory diseases in children un
49 d neurological deficits following treatment, hospitalisation >5 days, overall morbidity and mortality
50 d by 14% considering the general increase in hospitalisation; however, accounting for diabetes preval
51 iratory virus infection is a common cause of hospitalisation in adults.
52 mic monitoring systems might reduce rates of hospitalisation in patients with heart failure.
53            Aerosol was the primary driver of hospitalisations in drought affected municipalities duri
54 g that reduced funeral attendance and faster hospitalisation independently influenced local transmiss
55 ich safe burials are increased and effective hospitalisation instituted under two scenarios: (i) one
56 d old age is associated with non-psychiatric hospitalisation, longer length of stay and higher mortal
57      Serious adverse reactions necessitating hospitalisation occurred in 33 infants (16 on hormonal t
58 uneral contacts: severe symptoms, death, non-hospitalisation, older age, and travelling prior to symp
59      The primary endpoint was cardiovascular hospitalisation or cardiovascular death, with a hazard r
60 entration were associated with heart failure hospitalisation or death (PM2.5 2.12% per 10 mug/m(3), 9
61                                Heart failure hospitalisation or death was associated with increases i
62                           For the incidence (hospitalisation or death) rates of specific diseases, RR
63 ed to a different treatment model because of hospitalisation or travel (58 patients), leaving 4,173 T
64 um [PM10]) air pollutants, and heart failure hospitalisations or heart failure mortality.
65 chiatric disorders and psychiatric inpatient hospitalisation, premature mortality (before age 41 y),
66                                   The annual hospitalisation rate varies from a low of about 3 per 10
67 evidence for decreased acute chest syndrome, hospitalisation rates, and transfusion.
68                      There was evidence that hospitalisation reduced but did not eliminate onward exp
69 sequelae; and (iii) compare sequelae risk by hospitalisation status and pathogen.
70 uropean countries, but less likely to report hospitalisation than in Canada and Australia.
71     The combination of mask use with reduced hospitalisation time and a shift to outpatient therapy c
72 incidence rate ratio for repeat ED visits or hospitalisations was 0.89 (95% CI, 0.86 to 0.93) for sei
73 ts diagnosed prior to or up to 30 days after hospitalisation were defined as prevalent diabetes and w
74          No serious adverse events requiring hospitalisation were reported after immunisation.
75  in slope for total, elective, and emergency hospitalisations were -0.2% (95% CI -0.6%-0.2%; p = 0.25
76        In 6 months, 83 heart-failure-related hospitalisations were reported in the treatment group (n
77 ence of peripheral artery disease (including hospitalisation with a diagnosis of peripheral artery di
78                                      Risk of hospitalisation with any form of bipolar disorder fell i
79 ed, was associated with an increased risk of hospitalisation with asthma but no difference in risk of
80                                      Risk of hospitalisation with asthma was greater following both u
81 tcomes assessed included obesity at age 5 y, hospitalisation with asthma, learning disability, cerebr
82                                              Hospitalisations with a discharge diagnosis of an acute
83 ate of ischaemia-driven revascularisation or hospitalisation without revascularisation in patients wi
84 driven revascularisation or ischaemia-driven hospitalisation without revascularisation.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。